Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

476 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 Men.
Jia AY, Sun Y, Patel M, Baydoun A, Vince RA, Shoag JE, Brown JR, Barata PC, Schipper MJ, Dess RT, Jackson WC, Roy S, Nguyen PL, Berlin A, Mehra R, Schaeffer EM, Kashani R, Kishan AU, Zaorsky NG, Morgan TM, Spratt DE. Jia AY, et al. Among authors: schaeffer em. JCO Precis Oncol. 2025 Jun;9:e2400705. doi: 10.1200/PO-24-00705. Epub 2025 Jun 6. JCO Precis Oncol. 2025. PMID: 40479622
Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer.
Gharzai LA, Jiang R, Jaworski EM, Morales Rivera K, Dess RT, Jackson WC, Hartman HE, Mehra R, Kishan AU, Solanki AA, Schaeffer EM, Feng FY, Zaorsky NG, Berlin A, Ponsky L, Shoag J, Sun Y, Schipper MJ, Garcia J, Spratt DE. Gharzai LA, et al. Among authors: schaeffer em. NEJM Evid. 2023 Apr;2(4):EVIDoa2200195. doi: 10.1056/EVIDoa2200195. Epub 2023 Mar 27. NEJM Evid. 2023. PMID: 38320030
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology.
Tward JD, Huang HC, Esteva A, Mohamad O, van der Wal D, Simko JP, DeVries S, Zhang J, Joun S, Showalter TN, Schaeffer EM, Morgan TM, Monson JM, Wallace JA, Bahary JP, Sandler HM, Spratt DE, Rodgers JP, Feng FY, Tran PT. Tward JD, et al. Among authors: schaeffer em. JCO Precis Oncol. 2024 Oct;8:e2400145. doi: 10.1200/PO.24.00145. Epub 2024 Oct 24. JCO Precis Oncol. 2024. PMID: 39447096 Free PMC article.
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials.
Roach M 3rd, Zhang J, Mohamad O, van der Wal D, Simko JP, DeVries S, Huang HC, Joun S, Schaeffer EM, Morgan TM, Keim-Malpass J, Chen E, Yamashita R, Monson JM, Naz F, Wallace J, Bahary JP, Wilke D, Batra S, Biedermann GB, Faria S, Hwang L, Sandler HM, Spratt DE, Pugh SL, Esteva A, Tran PT, Feng FY. Roach M 3rd, et al. Among authors: schaeffer em. JCO Clin Cancer Inform. 2025 May;9:e2400284. doi: 10.1200/CCI-24-00284. Epub 2025 May 9. JCO Clin Cancer Inform. 2025. PMID: 40344545 Clinical Trial.
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate Cancer.
Spratt DE, Tang S, Sun Y, Huang HC, Chen E, Mohamad O, Armstrong AJ, Tward JD, Nguyen PL, Lang JM, Zhang J, Mitani A, Simko JP, DeVries S, van der Wal D, Pinckaers H, Monson JM, Campbell HA, Wallace J, Ferguson MJ, Bahary JP, Schaeffer EM, Sandler HM, Tran PT, Rodgers JP, Esteva A, Yamashita R, Feng FY. Spratt DE, et al. Among authors: schaeffer em. NEJM Evid. 2023 Aug;2(8):EVIDoa2300023. doi: 10.1056/EVIDoa2300023. Epub 2023 Jun 29. NEJM Evid. 2023. PMID: 38320143 Free PMC article.
NCCN Guidelines® Insights: Prostate Cancer, Version 3.2024.
Schaeffer EM, Srinivas S, Adra N, An Y, Bitting R, Chapin B, Cheng HH, D'Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Gupta S, Guzzo T, Ippolito JE, Karnes RJ, Kuettel MR, Lang JM, Lotan T, McKay RR, Morgan T, Pow-Sang JM, Reiter R, Roach M, Robin T, Rosenfeld S, Shabsigh A, Spratt D, Szmulewitz R, Teply BA, Tward J, Valicenti R, Wong JK, Snedeker J, Freedman-Cass DA. Schaeffer EM, et al. J Natl Compr Canc Netw. 2024 Apr;22(3):140-150. doi: 10.6004/jnccn.2024.0019. J Natl Compr Canc Netw. 2024. PMID: 38626801
Transperineal vs Transrectal Prostate Biopsy-The PREVENT Randomized Clinical Trial.
Hu JC, Assel M, Allaf ME, Vickers AJ, Ehdaie B, Cohen AJ, Green DA, Ghazi A, Ristau BT, Kowalczyk KJ, George AK, Patel HD, Montgomery JS, Han M, Rezaee M, Pavlovich CP, Patel NA, Ross AE, Kundu SD, Wang GJ, Shoag JE, Singla N, Stensland K, Gorin MA, Schaeffer AJ, Schaeffer EM. Hu JC, et al. Among authors: schaeffer aj, schaeffer em. JAMA Oncol. 2024 Sep 19;10(11):1590-3. doi: 10.1001/jamaoncol.2024.4000. Online ahead of print. JAMA Oncol. 2024. PMID: 39298143
Negative Predictive Value of a Prostate MRI in Black Men: Implications for Biopsy Decision-Making.
Sandlow S, Carbunaru S, Sun Z, Ofori B, Liu Y, Li E, Hollowell CMP, Vidal P, Perry KT Jr, Patel HD, Dobbs RW, Casalino DD, Wood CG 3rd, Jawahar A, Amarasekera C, Horowitz JM, Miller FH, Gumusgoz E, Yang XJ, Choy B, Manosca F, Bagci U, Schaeffer EM, Gann P, French DD, Ross AE, Kundu SD, Murphy AB. Sandlow S, et al. Among authors: schaeffer em. J Urol. 2025 Jun;213(6):713-721. doi: 10.1097/JU.0000000000004498. Epub 2025 Mar 17. J Urol. 2025. PMID: 40096657
476 results